165 related articles for article (PubMed ID: 32233134)
1.
Chang YJ; Bae J; Zhao Y; Lee G; Han J; Lee YH; Koo OJ; Seo S; Choi YK; Yeom SC
J Vet Sci; 2020 Mar; 21(2):e26. PubMed ID: 32233134
[TBL] [Abstract][Full Text] [Related]
2. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
3. Engineered Campylobacter jejuni Cas9 variant with enhanced activity and broader targeting range.
Nakagawa R; Ishiguro S; Okazaki S; Mori H; Tanaka M; Aburatani H; Yachie N; Nishimasu H; Nureki O
Commun Biol; 2022 Mar; 5(1):211. PubMed ID: 35260779
[TBL] [Abstract][Full Text] [Related]
4. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni.
Kim E; Koo T; Park SW; Kim D; Kim K; Cho HY; Song DW; Lee KJ; Jung MH; Kim S; Kim JH; Kim JH; Kim JS
Nat Commun; 2017 Feb; 8():14500. PubMed ID: 28220790
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus.
Jo DH; Koo T; Cho CS; Kim JH; Kim JS; Kim JH
Mol Ther; 2019 Jan; 27(1):130-136. PubMed ID: 30470629
[TBL] [Abstract][Full Text] [Related]
6. Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery.
Kweon J; Jang AH; Kwon E; Kim U; Shin HR; See J; Jang G; Lee C; Koo T; Kim S; Kim Y
Exp Mol Med; 2023 Feb; 55(2):377-384. PubMed ID: 36720917
[TBL] [Abstract][Full Text] [Related]
7. Functional Rescue of Dystrophin Deficiency in Mice Caused by Frameshift Mutations Using Campylobacter jejuni Cas9.
Koo T; Lu-Nguyen NB; Malerba A; Kim E; Kim D; Cappellari O; Cho HY; Dickson G; Popplewell L; Kim JS
Mol Ther; 2018 Jun; 26(6):1529-1538. PubMed ID: 29730196
[TBL] [Abstract][Full Text] [Related]
8. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
9. AAV-CRISPR Persistence in the Eye of the Beholder.
Recchia A
Mol Ther; 2019 Jan; 27(1):12-14. PubMed ID: 30559070
[No Abstract] [Full Text] [Related]
10. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
11. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
12. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
[TBL] [Abstract][Full Text] [Related]
13. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
14. Fusion of SpCas9 to E. coli Rec A protein enhances CRISPR-Cas9 mediated gene knockout in mammalian cells.
Lin L; Petersen TS; Jensen KT; Bolund L; Kühn R; Luo Y
J Biotechnol; 2017 Apr; 247():42-49. PubMed ID: 28259533
[TBL] [Abstract][Full Text] [Related]
15. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.
Swiech L; Heidenreich M; Banerjee A; Habib N; Li Y; Trombetta J; Sur M; Zhang F
Nat Biotechnol; 2015 Jan; 33(1):102-6. PubMed ID: 25326897
[TBL] [Abstract][Full Text] [Related]
16. Efficient and specific generation of knockout mice using
Lee JY; Jang YJ; Bae JH; Lee YH; Bae HS; Kim S; Park SG; Koo OJ; Yeom SC
Biochem Biophys Rep; 2020 Jul; 22():100752. PubMed ID: 32258440
[TBL] [Abstract][Full Text] [Related]
17. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
[TBL] [Abstract][Full Text] [Related]
18. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
19. Modeling Pancreatic Cancer through Somatic Editing with AAV.
Curiel-GarcÍa A; Olive KP
Trends Mol Med; 2019 May; 25(5):361-362. PubMed ID: 30878400
[TBL] [Abstract][Full Text] [Related]
20. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
Zhang D; Zhang B
Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
